146 related articles for article (PubMed ID: 16441422)
1. Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer.
Ishizone S; Yamauchi K; Kawa S; Suzuki T; Shimizu F; Harada O; Sugiyama A; Miyagawa S; Fukuda M; Nakayama J
Cancer Sci; 2006 Feb; 97(2):119-26. PubMed ID: 16441422
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the real-time reverse transcription-polymerase chain reaction assay targeted to alpha1,4-N-acetylglucosaminyltransferase for the detection of gastric cancer.
Shimizu F; Nakayama J; Ishizone S; Zhang MX; Kawakubo M; Ota H; Sugiyama A; Kawasaki S; Fukuda M; Katsuyama T
Lab Invest; 2003 Feb; 83(2):187-97. PubMed ID: 12594234
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of the expression of MUC4 mRNA in peripheral blood mononuclear cells of pancreatic cancer patients].
Li XH; Xiong JX; Wang CY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):624-7. PubMed ID: 16274046
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses.
Mataki Y; Takao S; Maemura K; Mori S; Shinchi H; Natsugoe S; Aikou T
Clin Cancer Res; 2004 Jun; 10(11):3807-14. PubMed ID: 15173089
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
6. High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1.
Kuramochi H; Hayashi K; Uchida K; Nakajima G; Hatori T; Danenberg KD; Danenberg PV; Yamamoto M
Cancer Chemother Pharmacol; 2008 Dec; 63(1):85-9. PubMed ID: 18309485
[TBL] [Abstract][Full Text] [Related]
7. Detection of the pancreas-specific gene in the peripheral blood of patients with pancreatic carcinoma.
Kuroki T; Tomioka T; Tajima Y; Inoue K; Ikematsu Y; Ichinose K; Furui J; Kanematsu T
Br J Cancer; 1999 Sep; 81(2):350-3. PubMed ID: 10496364
[TBL] [Abstract][Full Text] [Related]
8. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
9. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer.
Patel K; Whelan PJ; Prescott S; Brownhill SC; Johnston CF; Selby PJ; Burchill SA
Clin Cancer Res; 2004 Nov; 10(22):7511-9. PubMed ID: 15569981
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
[TBL] [Abstract][Full Text] [Related]
11. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
13. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
[TBL] [Abstract][Full Text] [Related]
14. Application of quantitative RT-PCR using "TaqMan" technology to evaluate the expression of CK 18 mRNA in various cell lines.
Tokunaga E; Maehara Y; Oki E; Koga T; Kakeji Y; Sugimachi K
J Exp Clin Cancer Res; 2000 Sep; 19(3):375-81. PubMed ID: 11144532
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
16. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
17. [Glycosyltransferase genes as tumor marker].
Nakayama J; Shimizu F; Katsuyama T
Rinsho Byori; 2002 Nov; Suppl 123():142-8. PubMed ID: 12652802
[TBL] [Abstract][Full Text] [Related]
18. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of surfactant protein D mRNA in peripheral blood of lung cancer patients].
Qi ZL; Xiao L; Gao YT; Du JM; Jing L
Ai Zheng; 2002 Jul; 21(7):772-5. PubMed ID: 12479105
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
